MediFind
Condition

Anthrax Infection

Symptoms, Doctors, Treatments, Research & More

Active Clinical Trials

Clinical Trial
Drug
  • Status: Not yet recruiting
  • Study Type: Drug
  • Participants: 10
  • Start Date: August 2021
An Observational Clinical Study of AIGIV Use in Sporadic Cases of Systemic Anthrax
Clinical Trial
Biological
  • Status: Active, not recruiting
  • Study Type: Biological
  • Participants: 42
  • Start Date: June 15, 2020
A Double-blind, Randomized, Placebo-controlled, Study of the Safety and Immunogenicity of NasoShield Administered as One or Two Doses in Different Dosing Positions
Clinical Trial
Diagnostic Test
  • Status: Recruiting
  • Study Type: Diagnostic Test
  • Participants: 440
  • Start Date: March 25, 2020
Evaluation of the Clinical Specificity of the Active Anthrax Detect™ Plus (AAD Plus) Lateral Flow Immunoassay (LFI)
Clinical Trial
Biological
  • Status: Active, not recruiting
  • Study Type: Biological
  • Participants: 145
  • Start Date: February 3, 2018
First-in-human, Randomized, Placebo-controlled, Double-blind, Dose-escalation Study of the Safety and Immunogenicity of NasoShield
Clinical Trial
Biological
  • Status: Active, not recruiting
  • Study Type: Biological
  • Participants: 580
  • Start Date: July 2012
BioThrax® (Anthrax) Vaccine in Pregnancy Registry